Neurogene Inc.(NGNE)

Biotechnology · New York City, NY

$25.40-1.07 (-4.04%)

Delayed quote: Oct 6, 2026, 3:50 PM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T19:53:12.705Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:53:12.705Z.

Quote observation: 2026-10-06T19:50:36.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow · period ending 2026-06-30: -86,236,271
Quote market capitalization: 401,379,080

FMP input reference: 8656b7a9da6ad27e4e3bee00a1f051c5b9ad9ad1f17b43070ca9e23e03b297bf

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

NGNE Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

NGNE Competitors' Operating Cash Flow Yield

NGNE

Neurogene Inc.

Current

Market Cap

$401.38M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Shoulder Innovations, Inc.

vs NGNE

Market Cap

$400.87M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CARL

Carlsmed, Inc.

vs NGNE

Market Cap

$399.21M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MYGN

Myriad Genetics, Inc.

vs NGNE

Market Cap

$404.71M

Operating Cash Flow Yield

1.90%

TTM Avg

1.03%

3Y Avg

1.03%

5Y Avg

0.91%

AVIR

Atea Pharmaceuticals, Inc.

vs NGNE

Market Cap

$405.46M

Operating Cash Flow Yield

N/A

TTM Avg

24.51%

3Y Avg

24.51%

5Y Avg

24.51%

EIKN

Eikon Therapeutics, Inc. Common Stock

vs NGNE

Market Cap

$407.91M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RZLT

Rezolute, Inc.

vs NGNE

Market Cap

$409.37M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SRTA

Strata Critical Medical, Inc.

vs NGNE

Market Cap

$411.43M

Operating Cash Flow Yield

N/A

TTM Avg

2.44%

3Y Avg

2.44%

5Y Avg

2.42%

MPLT

MapLight Therapeutics, Inc.

vs NGNE

Market Cap

$412.06M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RGNX

REGENXBIO Inc.

vs NGNE

Market Cap

$386.70M

Operating Cash Flow Yield

N/A

TTM Avg

16.47%

3Y Avg

16.47%

5Y Avg

9.15%

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
Neurogene Inc. (NGNE)	$401.38M	N/A	N/A	N/A	N/A
Shoulder Innovations, Inc. (SI)vs ›	$400.87M	N/A	N/A	N/A	N/A
Carlsmed, Inc. (CARL)vs ›	$399.21M	N/A	N/A	N/A	N/A
Myriad Genetics, Inc. (MYGN)vs ›	$404.71M	1.90%	1.03%	1.03%	0.91%
Atea Pharmaceuticals, Inc. (AVIR)vs ›	$405.46M	N/A	24.51%	24.51%	24.51%
Eikon Therapeutics, Inc. Common Stock (EIKN)vs ›	$407.91M	N/A	N/A	N/A	N/A
Rezolute, Inc. (RZLT)vs ›	$409.37M	N/A	N/A	N/A	N/A
Strata Critical Medical, Inc. (SRTA)vs ›	$411.43M	N/A	2.44%	2.44%	2.42%
MapLight Therapeutics, Inc. (MPLT)vs ›	$412.06M	N/A	N/A	N/A	N/A
REGENXBIO Inc. (RGNX)vs ›	$386.70M	N/A	16.47%	16.47%	9.15%

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

NGNE Operating Cash Flow Yield Metrics

NGNE Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics